Does Blue Cross Medicare Cover Wegovy? Medicare Advantage Coverage Guide 2026
If you’re enrolled in through BCBS Medicare Advantage (from Blue Cross Blue Shield Association) frequently want to know whether the formulary covers Wegovy (semaglutide 2.4mg). The short answer is: coverage depends on specific formulary placement and clinical criteria.
Blue Cross Medicare’s Formulary Position on Wegovy
BCBS Medicare Advantage maintains a Part D formulary that categorizes medications by patient cost. For the 2026 plan year, Wegovy is usually classified as Tier 5 (Specialty) on most Blue Cross Medicare plan variants.
Practical implications:
- Cost-sharing: $100–$300+ depending on coverage phase
- Prior authorization: Required — your doctor must submit
- Quantity limits: Often enforced — standard 30-day supply limits
- Step therapy: Might need trying metformin, insulin, or other treatments first
Note that the coverage gap, you’ll owe a larger share before catastrophic coverage applies.
Coverage for FDA-Approved vs. Off-Label Use
For chronic weight management (FDA-approved):
- Blue Cross Medicare is more likely to approve Wegovy when prescribed for its FDA-approved indication
- PA criteria: clinical records showing medical necessity
- Approval rates are higher with proper documentation
For weight loss (for chronic weight management):
- Original Medicare Part D excludes anti-obesity medications under Part D
- That said: the Inflation Reduction Act may have changed formulary inclusion rules for GLP-1s prescribed for obesity
- Blue Cross Medicare may offer supplemental benefits that extend to weight management medications — review your plan’s specific formulary
Estimated Costs With Blue Cross Medicare
Understanding your actual cost for Wegovy on Blue Cross Medicare requires knowing your current coverage phase.
| Coverage Phase | Typical Cost |
|---|---|
| Initial Deductible ($590 in 2026) | You pay everything: $1,300–$1,500/month |
| Initial Coverage | Tier 4/5 copay |
| Coverage Gap (Donut Hole) | Significant coinsurance |
| Catastrophic Coverage | 5% coinsurance or $4.50–$11.20 copay |
Thanks to the Inflation Reduction Act, out-of-pocket Part D spending is capped at $2,000/year — which significantly helps GLP-1 users.
Tips for Getting Approved
- Ask for a tier exception — If tier placement is too high, your doctor can request a coverage exception with supporting documentation
- Check manufacturer support — Novo Nordisk offers patient assistance programs for qualifying patients (government plan restrictions may apply)
- Switch plans if needed — AEP (Oct 15–Dec 7) lets you compare formularies
- Check Low-Income Subsidy eligibility — Low-income beneficiaries can receive Extra Help (Low-Income Subsidy) that dramatically lower copays